DL-Tartaric acid structure
|
Common Name | DL-Tartaric acid | ||
---|---|---|---|---|
CAS Number | 133-37-9 | Molecular Weight | 150.087 | |
Density | 1.9±0.1 g/cm3 | Boiling Point | 399.3±42.0 °C at 760 mmHg | |
Molecular Formula | C4H6O6 | Melting Point | 200-206ºC | |
MSDS | Chinese USA | Flash Point | 209.4±24.4 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Use of DL-Tartaric acidDL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities[1][2]. |
Name | DL-Tartaric Acid |
---|---|
Synonym | More Synonyms |
Description | DL-Tartaric acid is a non-racemic mixture of L- and D-tartaric acids with antioxidant activities[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.9±0.1 g/cm3 |
---|---|
Boiling Point | 399.3±42.0 °C at 760 mmHg |
Melting Point | 200-206ºC |
Molecular Formula | C4H6O6 |
Molecular Weight | 150.087 |
Flash Point | 209.4±24.4 °C |
Exact Mass | 150.016434 |
PSA | 115.06000 |
LogP | -1.43 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.586 |
Stability | Stable. Incompatible with bases, oxidizing agents, reducing agents, silver. |
Water Solubility | H2O: 0.1 g/mL, clear | soluble |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H318 |
Precautionary Statements | P280-P305 + P351 + P338 + P310 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | 26-37/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2918120000 |
Precursor 10 | |
---|---|
DownStream 10 | |
HS Code | 2918120000 |
---|---|
Summary | HS:2918120000 (2s,3s)-2,3-dihydroxysuccinic acid VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB MFN tariff:6.5% General tariff:35.0% |
Leishmania amazonensis: characterization of an ecto-pyrophosphatase activity.
Exp. Parasitol. 137 , 8-13, (2014) Several ecto-enzymatic activities have been described in the plasma membrane of the protozoan Leishmania amazonensis, which is the major etiological agent of diffuse cutaneous leishmaniasis in South A... |
|
Enamel protection from acid challenge--benefits of marketed fluoride dentifrices.
J. Clin. Dent. 24(1) , 25-30, (2013) To determine the ability of various marketed dentifrices containing stabilized stannous fluoride (SnF2), sodium fluoride (NaF), or sodium monofluorophosphate (SMFP) to protect enamel against the earli... |
|
Using contemporary liquid chromatography theory and technology to improve capillary gradient ion-exchange separations.
J. Chromatogr. A. 1370 , 63-9, (2014) The gradient-performance limits of capillary ion chromatography have been assessed at maximum system pressure (34.5 MPa) using capillary columns packed with 4.1 μm macroporous anion-exchange particles... |
2,3-Dihydroxysuccinic acid |
(2R,3R)-(+)-Tartaric acid |
(2R,3R)-2,3-Dihydroxysuccinic acid |
(R,R)-(+)-tartaric acid |
Ordinary Tartaric Acid |
L-(+)-Tartarate |
L-tartaric acid |
UNII:4J4Z8788N8 |
Racemic Acid |
[R-(R*,R*)]-2,3-Dihydroxybutanedioic Acid |
(2R,3R)-tartaric acid |
Butanedioic acid, 2,3-dihydroxy-, (2R,3R)- |
L-2,3-Dihydroxybutanedioic Acid |
Tartarate |
EINECS 205-105-7 |
(R,R)-tartaric acid |
DL-2,3-Dihydroxybutanedioic acid |
(+)-(2R,3R)-Tartaric acid |
L-(+)-Tartrate |
Resolvable tartaric acid |
(+)-tartaric acid |
(2R,3R)-2,3-dihydroxybutanedioic acid |
Tartaric acid |
MFCD00071626 |
Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-rel- |
DL-Tartaric acid concentrate |
(+)-L-tartaric acid |
(+)-(R,R)-tartaric acid |